People with diabetes have a higher chance of getting Alzheimer's disease than people without diabetes. When researchers combined the results of many long-term studies, they found that having diabetes raises the risk of Alzheimer's by about 69%.
See the scientific wording
Diabetes mellitus is associated with an increased risk of Alzheimer's disease, with a pooled relative risk of 1.69 (95% CI 1.51-1.89) for individuals with diabetes compared to those without, based on a systematic review and meta-analysis of prospective studies.
Indication only — weak evidence
One low-scoring study points this way, but the evidence is still early.
What the research says
1 study reviewedSupporting (1)
Systematic Review With Meta-AnalysisMeta-analysis2020
This systematic review and meta-analysis pooled data from multiple prospective studies and found a significant harmful association between diabetes and Alzheimer's disease risk, with a relative risk of 1.69, indicating a 69% increase in risk for those with diabetes.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When a person has diabetes, their blood sugar is too high for a long time. This extra sugar sticks to brain cells and damages them. It also causes the brain to become inflamed and makes it harder for the brain to clean out harmful clumps of protein. The high sugar also hurts the tiny blood vessels in the brain, so the brain doesn't get enough oxygen. All of this damage together leads to memory loss and Alzheimer's disease.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
People with diabetes have a higher chance of getting Alzheimer's disease than people without diabetes. When researchers combined the results of many long-term studies, they found that having diabetes raises the risk of Alzheimer's by about 69%.
Mechanism
1 studyDiabetes causes high blood sugar and problems with insulin. This leads to damage in the brain from sugar sticking to cells, inflammation, and harmful protein clumps. It also hurts the blood vessels in the brain, so the brain doesn't get enough oxygen. Over time, this damage kills brain cells and causes Alzheimer's disease.
When a person has diabetes, their blood sugar is too high for a long time. This extra sugar sticks to brain cells and damages them. It also causes the brain to become inflamed and makes it harder for the brain to clean out harmful clumps of protein. The high sugar also hurts the tiny blood vessels in the brain, so the brain doesn't get enough oxygen. All of this damage together leads to memory loss and Alzheimer's disease.
Chronic high blood sugar in diabetes increases the formation of advanced glycation end products and reactive oxygen species in the brain.
These harmful molecules activate microglia and astrocytes, triggering neuroinflammation and the release of pro-inflammatory cytokines.
Insulin resistance impairs insulin signaling in neurons, reducing the activity of insulin-degrading enzyme, which normally breaks down amyloid-beta, leading to its accumulation and plaque formation.
Amyloid-beta plaques and neuroinflammation induce hyperphosphorylation of tau protein, forming neurofibrillary tangles inside neurons and disrupting their function.
Diabetes-associated microvascular damage and endothelial dysfunction reduce cerebral blood flow, causing hypoxia and additional neuronal injury.
The combined effects of amyloid plaques, tau tangles, inflammation, and reduced blood flow lead to progressive synaptic loss and neuronal death, manifesting as Alzheimer's disease.
Evidence from Studies
Supporting (1)
Community contributions welcome
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Meta-Analysis of Prospective Cohort Studies on Diabetes Mellitus and Alzheimer's Disease Risk
Comprehensive literature search of PubMed, Embase, and Cochrane databases for prospective cohort studies examining diabetes mellitus and incident Alzheimer's disease, with meta-analytic pooling of adjusted relative risks and dose-response analysis by diabetes duration and glycemic control
Randomized Trial of Intensive Glycemic Control vs Standard Care on Alzheimer's Disease Incidence
Randomized controlled trial of intensive glycemic control (HbA1c <6.5%) vs standard care (HbA1c 7-8%) in 10,000+ adults with type 2 diabetes, followed for 10+ years for incident Alzheimer's disease diagnosed by standardized criteria
Prospective Cohort Study of Diabetes Mellitus and Incident Alzheimer's Disease
Prospective cohort of 50,000+ adults without dementia at baseline, with diabetes status confirmed by medical records or HbA1c, followed for 10-20 years for incident Alzheimer's disease diagnosed by NIA-AA criteria, adjusting for age, sex, BMI, cardiovascular risk factors, and APOE genotype
Case-Control Study of Diabetes History and Alzheimer's Disease
Cases with biomarker-confirmed or autopsy-confirmed Alzheimer's disease compared to age- and sex-matched controls without dementia, with retrospective review of medical records for diabetes history and glycemic control
Cross-Sectional Study of Diabetes and Cognitive Impairment in Older Adults
Cross-sectional assessment of diabetes status (HbA1c or medical history) and cognitive function in a population-based sample of 10,000+ adults aged 65+, with Alzheimer's diagnosis confirmed by standardized neuropsychological testing and clinical evaluation